Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Has the time come to consider Omega-3 to be part of treatment protocol for atopy and neurodevelopmental disorder?

Breadcrumb

  • Home
  • Has The Time Come To Consider Omega-3 To Be Part of Treatment Protocol For Atopy and Neurodevelopmental Disorder?
  • Has the time come to consider Omega-3 to be part of treatment protocol for atopy and neurodevelopmental disorder?

Zainab Ali Mohammed Al-Mukhaini *

Diwan of Royal Court Medical Services, Sultanate of Oman.
 
Research Article
GSC Advanced Research and Reviews, 2021, 09(03), 010–012.
Article DOI: 10.30574/gscarr.2021.9.3.0289
DOI url: https://doi.org/10.30574/gscarr.2021.9.3.0289
Received on 02 October 2021; revised on 30 November 2021; accepted on 02 December 2021
 
Omega-3 fatty acid benefits health throughout life. It is especially important for children’s health. It improves symptoms of children with autism and other neurodevelopmental disorders by improving communication and language development and improving behaviour and cognitive function. It also helps in controlling asthma and other atopic conditions. Adding omega-3 to routine management plan for children with asthma, allergic rhinitis, and neurodevelopment worth consideration.
 
Omega-3; Essential fatty acid; Autism; Neurodevelopmental; Atopy
 
https://gscarr.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCARR-2021-…

Preview Article PDF

Zainab Ali Mohammed Al-Mukhaini. Has the time come to consider Omega-3 to be part of treatment protocol for atopy and neurodevelopmental disorder?. GSC Advanced Research and Reviews, 2021, 9(3), 010-012. Article DOI: https://doi.org/10.30574/gscarr.2021.9.3.0289

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution